[Clinical experiences with a new anabolic steroid: 2-formyl-17(alpha)methylandrosta-1,4-dien-11(alpha)17(beta)diol-3-one].
D000328:Adult; D000368:Aged; D045930:Anabolic Agents / Q000627:therapeutic use*; D000731:Androstanes / Q000627:therapeutic use*; D001835:Body Weight / Q000187:drug effects*; D005260:Female; D006801:Humans; D008107:Liver Diseases / Q000188:drug therapy; D008175:Lung Neoplasms / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D010024:Osteoporosis / Q000188:drug therapy
D045930:Anabolic Agents; D000731:Androstanes
Esperienze cliniche con un nuovo steroide anabolizzante: il 2-formil-17( )metilandrosta-1,4dien-11( )17( ) diol-3-one.